Triptans in prevention of menstrual migraine: a systematic review with meta-analysis
Open Access
- 30 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Journal of Headache and Pain
- Vol. 14 (1), 1-9
- https://doi.org/10.1186/1129-2377-14-7
Abstract
Randomized clinical trials (RCT) assessing the efficacy and tolerability of triptans compared with placebo as short-term prophylaxis of menstrual migraine (MM) were systematically reviewed in this study. Triptans, which interfere with the pathogenesis of migraine and are effective in relieving associated neurovegetative symptoms, have been extensively proposed for prevention of menstrual migraine attacks. We searched Cochrane CENTRAL, MEDLINE and EMBASE for randomized, double-blind, placebo-controlled trials on triptans for MM until 1 Oct, 2012. A total of six RCTs were identified. Two authors independently assessed trial’s quality and extracted data. Numbers of participants free from MM per perimenstrual period (PMP), requiring rescue medication, suffering from headache-associated symptoms and experiencing adverse events in treatment and control groups were used to calculate relative risk (RR) and number needed to treat (NNT) with their corresponding 95% confidence interval (CI). A total of 633 participants received frovatriptan 2.5 mg QD, 584 received frovatriptan 2.5 mg BID, 392 received naratriptan 1 mg BID, 70 received naratriptan 2.5 mg BID, 80 received zolmitriptan 2.5 mg BID, 83 received zolmitriptan 2.5 mg TID and 1104 received placebo. Overall, triptans is an effective, short-term, prophylactic treatment of choice for MM. Considering MM frequency, severity and adverse events, frovatriptan 2.5 mg BID and zolmitriptan 2.5 mg TID tend to be the preferred regimens.This publication has 39 references indexed in Scilit:
- Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative studyThe Journal of Headache and Pain, 2012
- Transcranial magnetic stimulation of visual cortex in migraine patients: a systematic review with meta-analysisThe Journal of Headache and Pain, 2012
- Current Topics and Controversies in Menstrual MigraineHeadache: The Journal of Head and Face Pain, 2012
- Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptanThe Journal of Headache and Pain, 2011
- Almotriptan for menstrually related migraineExpert Opinion on Pharmacotherapy, 2011
- Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial RegisterThe Journal of Headache and Pain, 2011
- Genetics of Menstrual Migraine: The Epidemiological EvidenceCurrent Pain and Headache Reports, 2010
- Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice settingThe Journal of Headache and Pain, 2009
- Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraineThe Journal of Headache and Pain, 2007
- Nimesulide in the Treatment of Menstrual MigraineDrugs, 1993